Compounds such as schisandrin B and acetylshikonin (AS) activate the AMPK/mTOR pathway, stimulating hepatocyte autophagy and attenuating NAFLD progression (140, 141). The gene discussed is MTOR; the disease is metabolic dysfunction-associated steatotic liver disease.